Series D funding round for Atea Pharmaceuticals raising $220M in May 2020
Series D funding round for Atea Pharmaceuticals raising $220M in May 2020
| Investor | Firm Type | Partner |
|---|---|---|
| Venture Capital |
| — |
This company has completed 1 funding round. Current round is highlighted.
Total Raised
$220M
Top Valuation
-
Atea Pharmaceuticals raised $220M in a Series D round.
The round was announced on 05/01/20.